Explore

Capbase

Ensho Therapeutics, Inc. — Funding, Investors & Profile — Capbase

Private

Private securities offering disclosed via SEC Form D.

Biotechnology

$7.3MSource: [SEC]Raised (recorded)

UndisclosedSource: [SEC]Last valuation

Ensho Therapeutics, Inc. filed a Form D notice of exempt offering with the SEC.

1 round

1 round recorded · latest Private placement (Form D), Oct 2026 · $7.3M recorded

No investors recorded yet for Ensho Therapeutics, Inc..

Leadership

Danielle FryExecutive OfficerSince 2026Source: [SEC]

Ensho Therapeutics, Inc. has no recorded acquisitions.

Still private — no exit on record.

No diversity signals recorded yet for Ensho Therapeutics, Inc..

Data aggregated from SEC EDGAR, Wikidata, and community contributions. Spotted an error? Propose a change or report an issue.

Stage

Series A

Sector

Healthcare